GENEVA, July 1 -- ADVERIO PHARMA GMBH (Kaiser-Wilhelm-Allee 151373 Leverkusen) filed a patent application (PCT/EP2024/086170) for "DOSE REGIMEN FOR VERICIGUAT" on Dec 13, 2024. With publication no. WO/2025/132065, the details related to the patent application was published on Jun 26, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): CORDA, Stefano (Markgraflerstrasse 414057 Basel), BECKER, Corina (Augsburger Strasse 2640597 Dusseldorf), BRATTI, Monica (Chausseestr. 58E10115 Berlin), SCHULZE ZUMLOH, Monika (Flatowallee 2114055 Berlin), MCMULLAN, Ciaran Joseph (c/o Merck & Co., Inc.126 East Linc...